An Advanced Airway-on-a-Chip Model for Studying Pulmonary Fibrosis

By

Studying pulmonary fibrosis and lung disease is challenging due to the lack of realistic preclinical models. Our Airway-on-a-Chip (AoC) system replicates the human airway microenvironment, integrating unidirectional flow, perfusable microvascular networks, and differentiated epithelium for high-throughput drug testing and disease modeling.This innovative model captures fibrotic remodeling, inflammation, and vascular interactions, making it a powerful tool for respiratory drug discovery.Key Features of the ModelUnidirectional, gravity-driven flow for realistic airway fluid dynamicsPerfusable microvascular networks for vascular-lung interactionsCiliated & basal epithelial cells with mucus production for physiological relevanceHigh-throughput scalability, enabling parallel culture of 32 airway models

An Advanced Airway-on-a-Chip Model for Studying Pulmonary Fibrosis

By

An Advanced Airway-on-a-Chip Model for Studying Pulmonary Fibrosis

An advanced Airway-on-a-Chip model that mimics the human airway microenvironment to study pulmonary fibrosis, combining vascular interaction, mucus-producing epithelium, and high-throughput scalability for drug discovery and disease modeling.

An Advanced Airway-on-a-Chip Model for Studying Pulmonary Fibrosis

An advanced Airway-on-a-Chip model that mimics the human airway microenvironment to study pulmonary fibrosis, combining vascular interaction, mucus-producing epithelium, and high-throughput scalability for drug discovery and disease modeling.

No items found.

An Advanced Airway-on-a-Chip Model for Studying Pulmonary Fibrosis

An advanced Airway-on-a-Chip model that mimics the human airway microenvironment to study pulmonary fibrosis, combining vascular interaction, mucus-producing epithelium, and high-throughput scalability for drug discovery and disease modeling.

An Advanced Airway-on-a-Chip Model for Studying Pulmonary Fibrosis

An advanced Airway-on-a-Chip model that mimics the human airway microenvironment to study pulmonary fibrosis, combining vascular interaction, mucus-producing epithelium, and high-throughput scalability for drug discovery and disease modeling.

An Advanced Airway-on-a-Chip Model for Studying Pulmonary Fibrosis

An advanced Airway-on-a-Chip model that mimics the human airway microenvironment to study pulmonary fibrosis, combining vascular interaction, mucus-producing epithelium, and high-throughput scalability for drug discovery and disease modeling.

An Advanced Airway-on-a-Chip Model for Studying Pulmonary Fibrosis

An advanced Airway-on-a-Chip model that mimics the human airway microenvironment to study pulmonary fibrosis, combining vascular interaction, mucus-producing epithelium, and high-throughput scalability for drug discovery and disease modeling.

By

An Advanced Airway-on-a-Chip Model for Studying Pulmonary Fibrosis

An advanced Airway-on-a-Chip model that mimics the human airway microenvironment to study pulmonary fibrosis, combining vascular interaction, mucus-producing epithelium, and high-throughput scalability for drug discovery and disease modeling.

An Advanced Airway-on-a-Chip Model for Studying Pulmonary Fibrosis

An advanced Airway-on-a-Chip model that mimics the human airway microenvironment to study pulmonary fibrosis, combining vascular interaction, mucus-producing epithelium, and high-throughput scalability for drug discovery and disease modeling.

By